RxDoctor Payments Data

Adenike Awotundun

Family · Steelton, PANPI 1174085575

Payments from drug & device makers

$1,273in general payments, 2019–2025

Across 58 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$295
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$140
  • Pfizer$107
  • GSK$104
  • Exact Sciences$81
  • Boehringer Ingelheim$67
  • plus $480 from 15 others

What the payments were for

  • Food & beverage$1,273100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,273 in reported general payments places this provider in the 75th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin122$111,148
TrulicityDulaglutide23$35,663
EliquisApixaban37$31,084
TradjentaLinagliptin44$30,556
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$27,906
MounjaroTirzepatide11$19,190
XareltoRivaroxaban11$11,259
JanuviaSitagliptin Phosphate11$6,968
Diclofenac Sodium112$6,757
BrilintaTicagrelor12$6,204
Albuterol Sulfate HfaAlbuterol Sulfate154$5,442
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,815
PradaxaDabigatran Etexilate Mesylate15$2,983
SymbicortBudesonide/Formoterol Fumarate11$2,290
Ezetimibe47$2,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Pradaxa$67$144,687181 claims
Lilly USA, LLCTrulicity, Mounjaro$295$54,85334 claims
PfizerEliquis$107$31,08437 claims
GSKTrelegy Ellipta$104$27,90642 claims
AstraZenecaBrilinta, Symbicort$21$8,49423 claims
MerckJanuvia$61$6,96811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,717 family providers in Pennsylvania.

Other family in Steelton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →